Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 133,323 $ 226,204
Equity method investments 1,871,168 1,759,651
Receivables 1,437,000  
Receivables held-for-sale 65,749 22,214
Real estate 359,867 356,088
Investments 16,501 17,697
Securitization assets 192,178 210,354
Other assets 146,253 132,165
Total Assets 4,221,729 4,148,311
Liabilities:    
Accounts payable, accrued expenses and other 90,895 88,866
Credit facilities 100,464 100,473
Commercial paper notes 75,172 50,094
Non-recourse debt (secured by assets of $567 million and $573 million, respectively) 424,441 429,869
Senior unsecured notes 1,774,900 1,762,763
Convertible notes 141,863 149,731
Total Liabilities 2,607,735 2,581,796
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 86,719,735 and 85,326,781 shares issued and outstanding, respectively 867 853
Additional paid in capital 1,783,938 1,727,667
Accumulated deficit (181,282) (193,706)
Accumulated other comprehensive income (loss) (12,341) 9,904
Non-controlling interest 22,812 21,797
Total Stockholders’ Equity 1,613,994 1,566,515
Total Liabilities and Stockholders’ Equity 4,221,729 4,148,311
Commercial receivables    
Assets    
Receivables 1,320,507 1,298,529
Government receivables    
Assets    
Receivables $ 116,183 $ 125,409